Tunlametinib drug page Clinical trials

Trials with Tunlametinib

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
1Countries
165Planned patients

Showing 1–1 of 1

Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
Recruiting Phase 3 165 patients NCT06008119

This is a multicenter, randomized, open-label, Phase 3 study

China Oct 2023 – Dec 2026 Interventional
Combined with: Vemurafenib

Where the recruiting trials are